Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Clinuvel Pharmaceuticals (UR9A.F) Q3 2021 Earnings
UR9A.F
26
Aug
Confirmed
Q1 2021
Q3 2021
0.09
0.13
0.18
0.22
Details
Expected EPS
N/A
Actual EPS
0.2216513859219492
Surprise EPS
0.22
Surprise Percent
+∞%
Description
Clinuvel Pharmaceuticals (UR9A.F) has reported earnings of 0.2216513859219492 per share for Q3 2021.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login